Clover Health Investments Corp - Ordinary Shares - Class A Stock News

New Jersey Native Joseph Brand to Lead Operational Efficiency and Innovation in MA Operations, Enhancing Care for Physicians and Patients New Jersey Native Joseph Brand to Lead Operational Efficiency and Innovation in MA Operations, Enhancing Care for Physicians and Patients

FRANKLIN, Tenn., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Today, Counterpart Health, Inc . (“Counterpart”), a leading AI-powered physician enablement platform, announced a multi-year agreement with The Iowa Clinic, P.C ., one of the most highly regarded multispecialty healthcare groups in the United States. This deal positions The Iowa Clinic as one of Counterpart's anchor customers in the Midwest, a...

FRANKLIN, Tenn., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2024 Wells Fargo Healthcare Conference on Wednesday...

Clover Health Investments posted its first profitable quarter as a public company and raised its full-year guidance in Q2. Clover Health's star rating increased by 0.5 stars, which could have a positive impact on future top line and bottom line growth. Clover Health's star rating increase is a testament to the effectiveness of Clover Assistant, which could drive demand for the platform, in my o...

Clover Health (NASDAQ: CLOV ) co-founder and Executive Chairman Vivek Garipalli bought 531,700 shares of his troubled health insurance company this month. The executive now owns over 1.4 million shares.

Markets tanked on Monday because the Japanese central bank raised its interest rate to 0.25%. Interest rates were originally at a benchmark between 0 and 0.1, meaning a minor 15- to 25-basis-point increase had significant consequences for investors who were making margin calls with Yen.

Clover Health Investments, Corp. (NASDAQ:CLOV ) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Ryan Schmidt - IR Andrew Toy - CEO Peter Kuipers - CFO Conference Call Participants Richard Close - Canaccord Genuity Inc. Jason Cassorla - Citigroup Whit Mayo - Leerink Partners Operator Ladies and gentlemen good afternoon, and welcome to the Clover Health Second Quar...

Total Revenue growth for the Second Quarter of 2024 of 11% year-over-year GAAP Net Income from Continuing Operations during the Second Quarter of 2024 of $7.2 million versus Second Quarter 2023 GAAP loss of $28.9 million Adjusted EBITDA profitability for the Second Quarter of 2024 of $36.2 million versus Second Quarter 2023 Adjusted EBITDA of $9.9 million Increases Full-Year 2024 guidance to In...